SignalChem Lifesciences Corporation
SignalChem Lifesciences Corporation discovers and develops targeted therapies to treat cancer, IBD, RA, Parkinson, and Alzheimer's disease.
SignalChem Lifesciences Corporation (SLC) discovers and develops innovative novel small molecule targeted therapies for the treatment of cancer, inflammation/autoimmune and central nervous system diseases with unmet medical need. SLC addresses the growing market demand within and upon the pharmaceutical drug development industry for targeted therapies. SLC's products enable selection of the right drug for the right disease in the right patient.